With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|
|Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2017||California|
|Development of Mithramycin Analogs for Ewing sarcoma||Van Andel Research Institute / Patrick Grohar, MD/PhD||Innovation Grants||2017||Michigan|
|Targeting Metabolic Vulnerabilities in ETP-ALL||Columbia University / Adolfo A. Ferrando, MD/PhD||Innovation Grants||2017||New York|
|Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS||National Jewish Health / Jordan Jacobelli, PhD||Innovation Grants||2017||Colorado|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|
|Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response||Massachusetts General Hospital / Johnathan Whetstine, PhD||Innovation Grants||2015||Massachusetts|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Synergistic Differentiation Therapy in Neuroblastoma||Duke University / Gerard Blobe, M.D./Ph.D||Innovation Grants||2015||North Carolina|
|Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia||Boston Children's Hospital / Alan Cantor, MD, PhD||Innovation Grants||2015||Massachusetts|